Skip to main content
Log in

Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer's disease

  • Original Investigations
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Summary

A blind study showing that serum from patients with Alzheimer's disease causes immunolysis of mammalian brain synaptosomes is reported. Control, aged-matched, sera were largely without effect. The immunolysis was directed mainly against cholinergic synaptosomes. The data presented support the hypothesis that autoimmune mechanisms may operate in the pathogenesis of Alzheimer's disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adolfsson R, Gottfries CG, Roos BE, Winblad B (1979) Changes in brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry 135:216–223

    Google Scholar 

  2. Alafuzoff I, Adolfsson R, Bucht G, Winblad B (1983) Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and mulit-infarct dementia. J Neurol Sci 60:465–472

    Google Scholar 

  3. American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, 3rd edn. Washington, pp 205–224

  4. Blessed G (1980) Clinical aspects of the senile dementias. In: Roberts PJ (ed) Biochemistry of dementia. Wiley, Chichester, pp 1–14

    Google Scholar 

  5. Bradford HF, Bennett GW, Thomas AJ (1973) Depolarizing stimuli and the release of physiologically active amino acids from suspensions of mammalian synaptosomes. J Neurochem 21:495–505

    Google Scholar 

  6. Chang CH, Teng EL, Henderson VW, Moy AC (1985) Clinical subtypes of dementia of the Alzheimer type. Neurology 35:1544–1550

    Google Scholar 

  7. Chapman J, Korczyn AD, Hareuveni M, Michaelson DM (1986) Antibodies to cholinergic cell bodies in Alzheimer's disease. In: Fisher A, Hanin I, Lachman C (eds) Alzheimer's and Parkinson's diseases: strategies for research and development. Plenum Press, New York, pp 329–336

    Google Scholar 

  8. Dixon WJ (1983) (ed) Biomedical Data Processing Programm (BMDP), revised printing. University of California Press, Berkeley

    Google Scholar 

  9. Docherty M, Bradford HF (1986) A cell surface antigen of cholinergic nerve terminals recognized by antisera to choline acetyltransferase. Neurosci Lett 70:234–238

    Google Scholar 

  10. Docherty M, Bradford HF, Anderton BH (1982) Lysis of cholinergic synaptosomes by an antiserum to choline acetyltransferase. Biochem Soc Trans 10:368–369

    Google Scholar 

  11. Docherty M, Bradford HF, Wu J-Y, Joh TH, Reis DJ (1985) Evidence for specific immunolysis of nerve terminals using antisera against choline acetyltransferase, glutamate decarboxylase and tyrosine hydroxylase. Brain Res 339:105–113

    Google Scholar 

  12. Docherty M, Bradford HF, Joh TH (1986) Specific lysis of noradrenergic synaptosomes by an antiserum to dopamine-β-hydroxylase. FEBS Lett 202:37–40

    Google Scholar 

  13. Fillit H. Luine VN, Reisberg B, Amador R, McEwen B, Zabriskie JB (1985) Studies of the specificity of antibrain antibodies in Alzheimer's disease. In: Hutton JT, Kenny AD (eds) Senile dementia of the Alzheimer type. Liss, New York, pp 307–318

    Google Scholar 

  14. Fillit HM, Kemeny E, Luine V, Weksler ME, Zabriskie JB (1987) Antivascular antibodies in the sera of patients with senile dementia of the Alzheimer's type. J Gerontol 42:180–184

    Google Scholar 

  15. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198

    Google Scholar 

  16. Fonnum F (1969) Radio chemical microassays for the determination of choline acetyltransferase activities. Biochem J 115:465–472

    Google Scholar 

  17. Hardy J, Adolfsson R, Alafuzoff I (1985) Transmitter deficits in Alzheimer's disease. Neurochem Int 7:545–563

    Google Scholar 

  18. Hardy J, Mann DMA, Wester P, Winblad B (1986) An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiol Aging 7:489–502

    Google Scholar 

  19. Joh TH, Ross RA, Reis DJ (1974) A simple and sensitive assay for dopamine-β-hydroxylase. Anal Biochem 62:248–254

    Google Scholar 

  20. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939–944

    Google Scholar 

  21. McRae-Degueurce A, Booj S, Haglid K, Rosengren L, Karlsson JE, Karlsson I, Wallin A, Svennerholm L, Gottfries CG, Daglstrom A (1987) Antibodies in cerebrospinal fluid of some Alzheimer disease patients recognize cholinergic neurons in the rat central nervous system. Proc Natl Acad Sci USA 84:9214–9218

    Google Scholar 

  22. Reisberg B, Ferris SH, De Leon MJ, Crook T (1982) The global deterioration scale for the assessment of primary degenerative dementia. Am J Pschiatry 139:1136–1139

    Google Scholar 

  23. Roberts PJ (ed) (1980) Biochemistry of dementia. Wiley, Chichester

    Google Scholar 

  24. Rosser MN, Svendsen C, Hunt SP, Mountjoy CQ, Roth M, Iversen LL (1982) The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes. Neurosci Lett 28:218–222

    Google Scholar 

  25. Sims NR, Bowen DM, Allen SJ, Smith CCT, Neary D, Thomas DJ, Davison AN (1983) Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem 40:503–509

    Google Scholar 

  26. Tomlinson BE (1980) The structural and quantitative aspects of the dementias. In: Roberts PJ (ed) Biochemistry of dementia. Wiley, Chichester, pp 15–52

    Google Scholar 

  27. Vassault A (1983) Lactate dehydrogenase, UV method. In: Bergmeyer HU, Bergmeyer J, Grabi M (eds) Methods of enzymatic analysis, vol 3. Enzymes 1: oxido reductases, transferases. Verlag Chemie, Weinheim, pp 118–126

    Google Scholar 

  28. Watts H, Kennedy PGE, Thomas (1981) The significance of anti-neuronal antibodies in Alzheimer's disease. J Neuroimmunol 1:107–116

    Google Scholar 

  29. Wilcock GK, Esiri MM, Bowen DM, Smith CCT (1982) Alzheimer's disease: correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci 57:407–417

    Google Scholar 

  30. Wisniewski HM, Kozlowski PB (1982) Evidence for blood-brain barrier changes in senile dementia of Alzheimer's type (AD/SDAT): Alzheimer's disease. Down's syndrome and aging. Ann NY Acad Sci 386:119–129

    Google Scholar 

  31. Wurtmann RJ, Blusztajn JK, Maire J-C (1985) “Auto cannibalism” of choline-containing membrane phospholipids in the pathogenesis of Alzheimer's disease — a hypothesis. Neurochem Int 7:369–372

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Foley, P., Bradford, H.F., Docherty, M. et al. Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer's disease. J Neurol 235, 466–471 (1988). https://doi.org/10.1007/BF00314249

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00314249

Key words

Navigation